SunGChenPWangK, et al.Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. 2019;70(7):621–6.
2.
NikolskyEMehranRLasicZ, et al.Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005;67(2):706–13.
3.
ShachamYOzAGRubinowEL, et al.Association of admission hemoglobin levels and acute kidney injury among myocardial infarction patients treated with primary percutaneous intervention. Can J Cardiol. 2015;31(1):50–5.
4.
ShachamYRubinowELSteinvilAKerenGRothAArbelY. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention. Clin Exp Nephrol. 2015;19(5):838–43.
5.
ShachamYOzAGRubinowEL, et al.Admission glucose levels and the risk of acute kidney injury in nondiabetic ST segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Cardiorenal Med. 2015;5(3):191–8.
6.
LazzeriCValenteSChiostriMPicarielloCAttanaPGensiniGF. ST-elevation myocardial infarction with preserved ejection fraction: the impact of worsening renal failure. Int J Cardiol. 2012;155(1):170–2.
